Clinical Trial Update: Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating combination chemotherapy with or without rituximab in relapsed non-Hodgkin's lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Lymphoma | Phase 3 | Status: COMPLETED